☆ 4.7 Article

Safety of BNT162b2 or CoronaVac COVID-19 vaccines in patients with heart failure: A self-controlled case series study

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2023)

Related references

Note: Only part of the references are listed.

Article Hematology

COVID-19 vaccines and risks of hematological abnormalities: Nested case-control and self-controlled case series study

Chor-Wing Sing et al.

Summary: Studies found no increased risk of hematological abnormalities after CoronaVac vaccination, but an increased risk of leukopenia was observed shortly after the second dose of BNT162b2. However, the incidence was much lower than following SARS-CoV-2 infections. The benefits of COVID-19 vaccination still outweigh the risk of hematological abnormalities.

AMERICAN JOURNAL OF HEMATOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine A Case-Control Study

Francisco Tsz Tsun Lai et al.

Summary: This study found a higher association between BNT162b2 vaccination and carditis, while no similar association was found for CoronaVac. The risk of carditis after BNT162b2 vaccination was mainly observed after the second dose. This increased risk should be weighed against the benefits of vaccination.

ANNALS OF INTERNAL MEDICINE (2022)

Add to Collection

Article Immunology

Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination

Gilbert T. Chua et al.

Summary: There is a significant increase in the risk of acute myocarditis/pericarditis following Comirnaty vaccination among Chinese male adolescents, especially after the second dose. It is recommended for Hong Kong adolescents to receive only one dose of the Comirnaty vaccine.

CLINICAL INFECTIOUS DISEASES (2022)

Add to Collection

Letter Medicine, General & Internal

Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older

Marie Joelle Jabagi et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Add to Collection

Article Medicine, General & Internal

Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021

Matthew E. Oster et al.

Summary: Based on reports in the US, the risk of myocarditis after receiving mRNA-based COVID-19 vaccines was increased, especially among adolescent males and young men, particularly after the second dose. This risk should be considered in the context of the benefits of COVID-19 vaccination.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Long-term cardiovascular outcomes of COVID-19

Yan Xie et al.

Summary: Individuals with COVID-19, even those who were not hospitalized during the acute phase of the infection, are at an increased long-term risk of various cardiovascular disorders. A study using national healthcare databases found that beyond the first 30 days after infection, individuals with COVID-19 have an elevated risk of developing cerebrovascular disorders, heart diseases, and other cardiovascular complications. The risk increases depending on the care setting during the acute phase.

NATURE MEDICINE (2022)

Add to Collection

Article Mathematical & Computational Biology

A modified self-controlled case series method for event-dependent exposures and high event-related mortality, with application to COVID-19 vaccine safety

Yonas Ghebremichael-Weldeselassie et al.

Summary: This paper proposes a modified self-controlled case series (SCCS) method to study the safety of COVID-19 vaccines. By using case studies and simulations, the authors investigate the biases that may arise from event-dependence and high event-related mortality, and present a new testing method.

STATISTICS IN MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong

Francisco Tsz Tsun Lai et al.

Summary: This study, using electronic health records from Hong Kong, found that adverse events following COVID-19 vaccination are rare for all groups, and there is no evidence of risk modification due to multimorbidity.

NATURE COMMUNICATIONS (2022)

Add to Collection

Article Infectious Diseases

Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study

Eric Yuk Fai Wan et al.

Summary: The study evaluated the risk of Bell's palsy after vaccination with BNT162b2 and CoronaVac, finding an increased risk of Bell's palsy following CoronaVac vaccination. However, the overall benefits and protective effects of the inactivated COVID-19 vaccine far outweigh the risk of this generally self-limiting adverse event.

LANCET INFECTIOUS DISEASES (2022)

Add to Collection

Letter Pediatrics

Myocarditis Following COVID-19 BNT162b2 Vaccination Among Adolescents in Hong Kong

Li Xue et al.

JAMA PEDIATRICS (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease

Xuxiao Ye et al.

Summary: The study found that there is no increased risk of major adverse cardiovascular events (MACE) after vaccination with BNT162b2 or CoronaVac in patients with cardiovascular disease (CVD).

CARDIOVASCULAR RESEARCH (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology

Giuseppe Rosano et al.

Summary: Patients with heart failure who contract SARS-CoV-2 infection are at higher risk of morbidity and mortality. COVID-19 vaccination is recommended for all patients with HF, including those who are immunocompromised or frail. After vaccination, patients should continue precautionary measures such as wearing masks, practicing hand hygiene, and maintaining social distancing.

EUROPEAN JOURNAL OF HEART FAILURE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19

Ankeet S. Bhatt et al.

Summary: This study found that patients with a history of HF hospitalized with COVID-19 have a higher mortality rate, with nearly one in four patients dying during hospitalization.

JACC-HEART FAILURE (2021)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

ACC Health Policy Statement on Cardiovascular Disease Considerations for COVID-19 Vaccine Prioritization A Report of the American College of Cardiology Solution Set Oversight Committee

Elissa Driggin et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Myocarditis With COVID-19 mRNA Vaccines

Biykem Bozkurt et al.

Summary: Myocarditis is a rare complication of COVID-19 mRNA vaccines, predominantly affecting young adult and adolescent males, with most patients showing improvement in symptoms. Possible mechanisms include molecular mimicry between viral proteins and self-antigens, dysregulated immune pathways, immune response to mRNA, and dysregulated cytokine expression.

CIRCULATION (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Clinical Characteristics and Outcomes of Adults With a History of Heart Failure Hospitalized for COVID-19

Parag Goyal et al.

Summary: This study found that adults with a history of heart failure had a higher risk of in-hospital mortality during COVID-19 infection, especially those with heart failure and reduced ejection fraction. Therefore, this population should be prioritized for COVID-19 vaccination.

CIRCULATION-HEART FAILURE (2021)

Add to Collection

Article Medicine, General & Internal

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults A Randomized Clinical Trial

Nawal Al Kaabi et al.

Summary: This interim analysis of an ongoing randomized trial in the UAE and Bahrain evaluated the efficacy of two inactivated COVID-19 vaccines in preventing symptomatic cases and adverse events in healthy adults. The study found that both vaccines significantly reduced the risk of symptomatic COVID-19 compared to the control group, with efficacy rates of 72.8% and 78.1%. Serious adverse events were rare across all groups.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination

Han W. Kim et al.

Summary: This study described 7 patients with acute myocarditis, 4 of whom had received mRNA COVID-19 vaccination. All patients presented with severe chest pain, biomarker evidence of myocardial injury, and were hospitalized. Cardiac magnetic resonance imaging findings were typical for myocarditis. Further investigation is needed to determine associations of COVID-19 vaccination and myocarditis.

JAMA CARDIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Recurrent heart failure hospitalizations are associated with increased cardiovascular mortality in patients with heart failure in Clinical Practice Research Datalink

Raquel Lahoz et al.

ESC HEART FAILURE (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications

Juan R. Rey et al.

EUROPEAN JOURNAL OF HEART FAILURE (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19

Jesus Alvarez-Garcia et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Self controlled case series methods: an alternative to standard epidemiological study designs

Irene Petersen et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Add to Collection

Article Medicine, General & Internal

Self controlled case series methods: an alternative to standard epidemiological study designs

Irene Petersen et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Add to Collection

Review Cardiac & Cardiovascular Systems

The Global Health and Economic Burden of Hospitalizations for Heart Failure Lessons Learned From Hospitalized Heart Failure Registries

Andrew P. Ambrosy et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

Add to Collection

Article Medicine, General & Internal

Dose-dependent Impact of Recurrent Cardiac Events on Mortality in Patients with Heart Failure

Douglas S. Lee et al.

AMERICAN JOURNAL OF MEDICINE (2009)

Add to Collection

Article Cardiac & Cardiovascular Systems

Repeated hospitalizations predict mortality in the community population with heart failure

Soko Setoguchi et al.

AMERICAN HEART JOURNAL (2007)

Add to Collection

Article Public, Environmental & Occupational Health

The ecology of health care in Hong Kong

GM Leung et al.

SOCIAL SCIENCE & MEDICINE (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.